Cargando…
LIP expression is regulated by IGF-1R signaling and participates in suppression of anoikis
BACKGROUND: The transcription factor, CCAAT enhancer binding protein-β (C/EBPβ), is expressed as several distinct protein isoforms (LAP1, LAP2 and LIP) that have opposing actions in cellular proliferation and differentiation. Increases in the ratio of LIP/LAP are associated with aggressive, metastat...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3176234/ https://www.ncbi.nlm.nih.gov/pubmed/21854628 http://dx.doi.org/10.1186/1476-4598-10-100 |
_version_ | 1782212199853326336 |
---|---|
author | Li, Huili Baldwin, Brenda R Zahnow, Cynthia A |
author_facet | Li, Huili Baldwin, Brenda R Zahnow, Cynthia A |
author_sort | Li, Huili |
collection | PubMed |
description | BACKGROUND: The transcription factor, CCAAT enhancer binding protein-β (C/EBPβ), is expressed as several distinct protein isoforms (LAP1, LAP2 and LIP) that have opposing actions in cellular proliferation and differentiation. Increases in the ratio of LIP/LAP are associated with aggressive, metastatic breast cancer; however, little is known regarding the molecular mechanisms that regulate LIP expression or the biological actions of an increase in the LIP/LAP ratio. Metastasis is highly dependent upon the suppression of anoikis and the role of C/EBPβ and LIP in this anchorage-independent, survival process is currently not known in mammary epithelial cells. IGF-1R signaling is important for the survival of breast cancer cells and crosstalk between IGF-1R and EGFR signaling pathways have been implicated in the development of more aggressive disease. We therefore evaluated in mammary epithelial cells whether IGF-1R signaling regulates the LIP/LAP ratio, analyzed the potential interplay between EGFR and IGF-1R signaling and addressed the biological significance of increased LIP expression in cellular survival and suppression of anoikis. RESULTS: Our data provide the first evidence that IGF-1R signaling regulates LIP expression in an EGFR independent manner to increase the LIP/LAP ratio in mammary epithelial cells. Although crosstalk between IGF-1R signaling and EGFR signaling is detectable in MCF10A cells, this crosstalk is not required for the IGF-1 mediated regulation of LIP expression. Rather, the critical regulator of IGF-1 induced LIP expression appears to be EGFR-independent, Akt activity. Our data also demonstrate that increases in LIP expression promote cell survival via suppression of anoikis. Likewise, knockdown of total C/EBPβ leads to increased cell death and suggest that C/EBPβ expression is important for survival and resistance to anoikis. IGF-1 treatment can partially rescue vector control cells from anoikis; however, cells with reduced C/EBPβ expression do not survive anoikis. CONCLUSIONS: Taken together, our data demonstrate that IGF-1R signaling regulates LIP expression in an EGFR independent manner to increase the LIP/LAP ratio in mammary epithelial cells. C/EBPβ expression and elevations in LIP play an important role in regulating cellular survival via suppression of anoikis, in an IGF-1R mediated context or in a manner independent of IGF-1R signaling. |
format | Online Article Text |
id | pubmed-3176234 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-31762342011-09-20 LIP expression is regulated by IGF-1R signaling and participates in suppression of anoikis Li, Huili Baldwin, Brenda R Zahnow, Cynthia A Mol Cancer Research BACKGROUND: The transcription factor, CCAAT enhancer binding protein-β (C/EBPβ), is expressed as several distinct protein isoforms (LAP1, LAP2 and LIP) that have opposing actions in cellular proliferation and differentiation. Increases in the ratio of LIP/LAP are associated with aggressive, metastatic breast cancer; however, little is known regarding the molecular mechanisms that regulate LIP expression or the biological actions of an increase in the LIP/LAP ratio. Metastasis is highly dependent upon the suppression of anoikis and the role of C/EBPβ and LIP in this anchorage-independent, survival process is currently not known in mammary epithelial cells. IGF-1R signaling is important for the survival of breast cancer cells and crosstalk between IGF-1R and EGFR signaling pathways have been implicated in the development of more aggressive disease. We therefore evaluated in mammary epithelial cells whether IGF-1R signaling regulates the LIP/LAP ratio, analyzed the potential interplay between EGFR and IGF-1R signaling and addressed the biological significance of increased LIP expression in cellular survival and suppression of anoikis. RESULTS: Our data provide the first evidence that IGF-1R signaling regulates LIP expression in an EGFR independent manner to increase the LIP/LAP ratio in mammary epithelial cells. Although crosstalk between IGF-1R signaling and EGFR signaling is detectable in MCF10A cells, this crosstalk is not required for the IGF-1 mediated regulation of LIP expression. Rather, the critical regulator of IGF-1 induced LIP expression appears to be EGFR-independent, Akt activity. Our data also demonstrate that increases in LIP expression promote cell survival via suppression of anoikis. Likewise, knockdown of total C/EBPβ leads to increased cell death and suggest that C/EBPβ expression is important for survival and resistance to anoikis. IGF-1 treatment can partially rescue vector control cells from anoikis; however, cells with reduced C/EBPβ expression do not survive anoikis. CONCLUSIONS: Taken together, our data demonstrate that IGF-1R signaling regulates LIP expression in an EGFR independent manner to increase the LIP/LAP ratio in mammary epithelial cells. C/EBPβ expression and elevations in LIP play an important role in regulating cellular survival via suppression of anoikis, in an IGF-1R mediated context or in a manner independent of IGF-1R signaling. BioMed Central 2011-08-19 /pmc/articles/PMC3176234/ /pubmed/21854628 http://dx.doi.org/10.1186/1476-4598-10-100 Text en Copyright ©2011 Li et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Li, Huili Baldwin, Brenda R Zahnow, Cynthia A LIP expression is regulated by IGF-1R signaling and participates in suppression of anoikis |
title | LIP expression is regulated by IGF-1R signaling and participates in suppression of anoikis |
title_full | LIP expression is regulated by IGF-1R signaling and participates in suppression of anoikis |
title_fullStr | LIP expression is regulated by IGF-1R signaling and participates in suppression of anoikis |
title_full_unstemmed | LIP expression is regulated by IGF-1R signaling and participates in suppression of anoikis |
title_short | LIP expression is regulated by IGF-1R signaling and participates in suppression of anoikis |
title_sort | lip expression is regulated by igf-1r signaling and participates in suppression of anoikis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3176234/ https://www.ncbi.nlm.nih.gov/pubmed/21854628 http://dx.doi.org/10.1186/1476-4598-10-100 |
work_keys_str_mv | AT lihuili lipexpressionisregulatedbyigf1rsignalingandparticipatesinsuppressionofanoikis AT baldwinbrendar lipexpressionisregulatedbyigf1rsignalingandparticipatesinsuppressionofanoikis AT zahnowcynthiaa lipexpressionisregulatedbyigf1rsignalingandparticipatesinsuppressionofanoikis |